Guide RNA Comparison
Compare multiple guides against the same target sequence to identify stronger or weaker binding profiles before committing to downstream editing studies.
Insight Solution
DNA Target Binding
Measure how well CRISPR RNPs bind the DNA sequences that matter—before downstream editing readouts obscure the signal.
CRISPR editing begins with molecular recognition. The Cas protein acts as the engine. The guide RNA provides the targeting. But once the RNP forms, the critical question becomes: how well does that specific RNP bind the intended DNA target?
CRISPR QC measures target binding using controlled, chip-based assays designed to isolate the interaction between a defined CRISPR molecule and a defined DNA sequence. Instead of relying only on downstream editing outcomes—or purely computational guide predictions—our platform provides kinetic, concentration-dependent insight into how RNPs interact with on-target and potential off-target sequences.
Editing precision starts with target recognition.
In a CRISPR workflow, successful editing depends on more than delivery, RNP formation, or nuclease activity alone. The RNP must recognize and bind the correct DNA sequence with sufficient affinity to support the intended editing event.
That recognition step is difficult to evaluate using downstream outcomes alone. Editing efficiency, sequencing data, and cellular response can reflect many overlapping variables, including delivery, nuclear entry, RNP stability, chromatin accessibility, cleavage activity, repair pathway dynamics, and cell state.
DNA target binding analysis helps isolate one specific question:
How strongly does this CRISPR RNP bind this DNA sequence at this concentration?
By answering that question directly, researchers can compare guide RNAs, Cas variants, engineered proteins, on-target sequences, and known or suspected off-target sites with greater clarity.
A controlled, amplicon-based assay for CRISPR target binding.
CRISPR QC uses target-specific DNA amplicons to focus the assay on the sequence region that matters. Rather than applying whole genomic DNA and introducing billions of bases of complexity, the assay uses a defined DNA fragment containing the target sequence of interest.
This creates a controlled in vitro environment where the binding behavior of the CRISPR RNP can be measured with fewer confounding variables.
Defined Target Sequence
Use an amplicon containing the intended target region or a known off-target sequence.
Controlled RNP Input
Apply defined concentrations of Cas/RNP complexes to measure concentration-dependent binding behavior.
Real-Time Sensor Response
Generate kinetic binding curves that reveal how strongly and consistently the RNP interacts with the target DNA.
This approach is not meant to replace cellular or sequencing-based assays. It adds an upstream biochemical layer that helps explain why downstream editing results may vary.
From binding curves to actionable target affinity.
The DNA Target Binding assay measures sensor response across RNP concentrations to generate titration curves. These curves help characterize how much RNP is required to bind a specific DNA target and where the response begins to saturate.
At low concentrations, there may not be enough target-binding RNP present to generate a measurable response. As concentration increases, the sensor response rises through a quantitative range. At higher concentrations, the sensor reaches saturation, meaning additional RNP no longer produces a proportional increase in signal.
This concentration-response profile can help identify useful operating windows, compare binding performance across guide designs, and distinguish strong target affinity from weak or inefficient binding.
Understand the targets you want—and the targets you do not.
DNA target binding is not limited to the intended editing site. The same assay framework can be used to evaluate known or suspected off-target sequences by creating amplicons that contain those regions.
This is especially important because off-target risk is often concentration-dependent. A guide may strongly prefer the intended target, but still retain some probability of binding a similar off-target sequence. At higher RNP concentrations, the probability of off-target engagement may increase even if on-target binding is already saturated.
This type of comparison can help define a practical concentration range: high enough to support on-target engagement, but not so high that it increases the likelihood of unwanted off-target binding.
This assay provides a biochemical target-binding readout that informs editing design, optimization, and risk assessment—it does not alone prove editing outcome or off-target editing frequency.
Designed for guide optimization, Cas engineering, and precision editing development.
Cas Variant Evaluation
Assess how engineered Cas proteins or alternative nuclease formats affect target recognition and binding behavior.
Off-Target Risk Exploration
Test known or suspected off-target amplicons to evaluate relative binding propensity across concentration ranges.
Dose and Concentration Optimization
Identify concentration ranges that support robust on-target binding while minimizing unnecessary excess RNP exposure.
One layer in a broader analytical view of CRISPR performance.
DNA target binding is one part of a larger CRISPR analytical framework. RNP formation tells you whether the Cas protein and guide RNA assemble properly. DNA target binding tells you whether that RNP recognizes the intended sequence. Cleavage analysis adds another layer by measuring catalytic activity after target engagement.
Together, these measurements help separate the causes of weak or inconsistent editing performance.
- 1
RNP Formation
Did the Cas protein and guide RNA assemble?
- 2
DNA Target Binding
Does the RNP bind the intended DNA sequence?
- 3
Cleavage Activity
Is the bound RNP catalytically active under appropriate conditions?
- 4
Editing Outcome
How does upstream biochemical behavior translate into cellular editing performance?
By isolating each step, CRISPR QC helps teams troubleshoot earlier, optimize more rationally, and reduce reliance on downstream readouts that combine multiple sources of variability.
Data outputs from DNA Target Binding analysis.
Target-specific binding curves
Concentration-response curves showing how RNPs bind defined DNA targets.
Relative target affinity
Comparative binding behavior across guides, Cas variants, target sequences, or off-target amplicons.
Quantitative response range
Identification of concentration ranges where binding response is measurable and informative.
Saturation behavior
Insight into where additional RNP no longer increases target-binding signal.
On-target/off-target comparison
Side-by-side analysis of intended targets and known or suspected off-target sequences.
Optimization guidance
Data to inform guide selection, RNP concentration, and downstream validation strategy.
Add target-binding data before downstream editing decisions.
CRISPR QC helps teams measure the biochemical steps that determine editing performance. Use DNA Target Binding analysis to compare guides, evaluate target affinity, explore off-target binding, and define better concentration ranges before moving deeper into development.
Common questions about DNA Target Binding
No. DNA Target Binding measures whether a CRISPR RNP binds a defined DNA target sequence. Editing efficiency depends on additional steps, including cleavage activity, delivery, nuclear localization, DNA repair, chromatin context, and cellular conditions.
Amplicons allow the assay to focus on a defined DNA region containing the target sequence of interest. This reduces complexity and helps isolate binding behavior against a specific on-target or off-target sequence.
Yes. Multiple guides can be evaluated against the same target sequence to compare relative binding behavior and concentration-response profiles.
Yes. Known or suspected off-target sequences can be incorporated into amplicons and compared against the intended target. This provides a biochemical view of relative binding propensity, especially across different RNP concentrations.
Not necessarily. Binding is necessary for editing, but it is not the only determinant. Cleavage activity, delivery, nuclear exposure, repair dynamics, and cellular context all influence the final editing outcome.
DNA Target Binding fits between RNP formation analysis and cleavage activity analysis. It helps determine whether a properly formed RNP recognizes the intended DNA sequence before measuring catalytic activity or downstream editing outcomes.